Clinical Trial Update: Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing TOOKAD Soluble to active surveillance for localized prostate cancer has completed evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TOOKAD Soluble (padeliporfin)

Snippet

Sponsor: Steba Biotech S.A. | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED